Affimed and NKMax America to Study the Combination of AFM24, an EGFR-Targeted Innate Cell Engager, with SNK01 Natural Killer Cell Therapy

NEXT STORY
National Survey Reveals Vital Need for COVID-19 Relief Support Beyond Canadian Border
PREV STORY
Over the Counter Test Market to hit US $33.88 billion by 2028 – Global Insights on Price Trends, Regulatory Landscape, Key Growth Drivers, COVID-19 Impact Analysis, Key Players and Future Prospect: Adroit Market Research
Subscribe now to PM360
Get in touch with PM360 Experts On Call

Experts on Call

Ads

You May Also Like

Skye Bioscience Appoints Biotech Executive Praveen Tyle, Ph.D. to Board of Directors

author_avatar
NASDAQ Market News

Tonix Pharmaceuticals Enters into Research Collaboration and Exclusive License Agreement with University of Alberta to Develop Novel Horsepox-Based Vaccines, TNX-1810, TNX-1820 and TNX-1830, for the Prevention of COVID-19

author_avatar
NASDAQ Market News

Leading Immunobiology Researcher Dr. David Briscoe Joins aTyr Pharma as Scientific Advisor

author_avatar
NASDAQ Market News